Abstract
Syndecan is a cell surface proteoglycan (Saunders et al., 1989), which was originally isolated from mouse mammary epithelial (NMuMG) cells as a hybrid proteoglycan containing both heparan sulfate and chondroitin sulfate glycosaminoglycan (GAG) chains (Rapraeger et al., 1985). The ratio and total amount of GAG bound to syndecan is known to vary in different tissues (Sanderson & Bernfield, 1988; Salmivirta et al., 1991) and cells (Rapraeger 1989). Syndecan binds several extracellular matrix molecules such as fibrillar collagens of interstitial matrix (Koda et al., 1985), fibronectin (Saunders & Bernfield, 1988) and thrombospondin (Sun et al., 1989) but shows no binding to some other heparin binding matrix molecules, like vitronectin and laminin (Koda et al., 1985; Elenius et al., 1990). Syndecan also binds growth factors, like bFGF (Kiefer et al., 1990), and could therefore play a major role in the regulation of cell adhesion, growth and differentiation (for a review see Jalkanen et al., 1991).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burgess, W.H., Maciag, T., 1989, The heparin-binding (fibroblast) growth factor family of proteins, Annu. Rev. Biochem., 58: 575–606.
Chiquet-Ehrismann, R., 1990, What distinguishes tenascin from fibronectin, FASEB J., 4: 2598–2604.
Chiquet, M., Vrucinic-Filipi, N., Schenk, S., Beck, K., and Chiquet-Ehrismann, R., 1991, Isolation of chick teneascin variants and fragments: A c-terminal heparin-binding fragment produced by cleavage of the extra domain from the largest subunit splicing variant, Eur. J. Biochem., in press.
Elenius, K., Salmivirta, M., Inki, P., Mali, M., and Jalkanen, M., 1990, Binding of human syndecan to extracellular matrix, J. Biol. Chem., 265: 17837–17843.
Elenius, K., Vainio, S., Laato, M., Salmivirta, M., Thesleff, I., and Jalkanen, M., 1991a, Induced expression of syndecan in healing wounds, J. Cell Biol., 114: 585–596.
Elenius, K., Määttä, A., Salmivirta, M., and Jalkanen, M., 1991b, Growth factors induce 3T3 cells to express bFGF-binding syndecan, EMBO J., submitted.
Gallagher, J.T., 1989, The extended family of proteoglycans: social residents of the pericellular zone, Curr. Opin. Cell Biol., 1: 1201–1218.
Jalkanen, M., Jalkanen, S., and Bernfield, M., 1991, Binding of extracellular effector molecules by cell surface proteoglycans, in: Receptors for extracellular matrix, J. MacDonald, and R. Mecham, Eds., Academic Press, San Diago, in press.
Kiefer, M.C., Stephans, J.C., Crawford, K., Okino, K. and Barr, P.J., 1990, Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor, Proc. Natl. Acad. Sci. USA, 87: 6985–6989.
Kjellen, L., and Lindahl, U., 1991, Proteoglycans: Structure and interactions, Annu. Rev. Biochem., 60: 443–75.
Koda, J., Rapraeger, A., and Bernfield, M., 1985, Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens, J. Biol. Chem., 260: 8157–8162.
Mali, M., Jaakkola, P., Arvilommi, A.-M., and Jalkanen, M., 1990, Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans, J. Biol. Chem., 265: 6884–6889.
Massague, J., 1990, The transforming growth factor-ß family, Annu. Rev. Cell Biol., 6: 597–642.
Rapraeger, A., Jalkanen, M., Endo, E., Koda, J., and Bernfield, M., 1985, The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans, J. Biol. Chem., 260: 11046–11052.
Rapraeger, A., 1989, Transforming growth factor (type ß) promotes the eaddition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia, J. Cell Biol., 109: 2509–2518.
Rapraeger, A., Krufka, A., Olwin, B.B., 1991, Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation, Science, 252: 1705–1708.
Salmivirta, M., Elenius, K., Vainio, S., Hofer, U., Chiquet-Ehrismann, R., Thesleff, I., and Jalkanen, M., 1991, Syndecan from tooth mesenchyme binds tenascin, J. Biol. Chem., 266: 7733–7739.
Sanderson, R., and Bernfield, M., (1988) Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia, Proc. Natl. Acad. Sci. USA, 85: 9562–9566.
Saunders, S., and Bernfield, M., 1988, Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix, J. Cell Biol., 106: 423–430.
Saunders, S., Jalkanen, M., O’Farrell, S., and Bernfield, M., 1989, Molecular cloning of syndecan, an integral membrane proteoglycan, J. Cell Biol., 108: 1547–1556.
Spring, J., Beck, K., and Chiquet-Ehrismann, R., 1989, Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments, Cell, 59: 325–334.
Stroker, A.W., Streuli, C.H., Martins-Green, M., and Bissell, M.J., 1990, Designer microenvironments for the analysis of cell and tissue function. Curr. Opin. Cell Biol., 2: 864–874.
Sun, X., Mosher, D.F., and Rapraeger, A., 1989, Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin, J. Biol. Chem., 264: 2885–2889.
Thesleff, I., Jalkanen, M., Vainio, S., and Bernfield, M., 1988, Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis, Dev. Biol., 129: 565–572.
Thesleff, I., Jalkanen, M., Partanen, A.-M., and Vainio, S., 1991, Molecular changes in dental mesenchyme during tooth development, in: “Aspects of Oral Molecular Biology. Frontiers of Oral Physiology”, Ferguson, D.B., Ed., S. Karger, Basel, vol. 8, pp 42–56.
Vaahtokari, A., Vainio, S., and Thesleff, I., 1991, Associations between transforming growth factor ß1 RNA expression and epithelial-mesenchymal interactions during tooth morphogenesis, Development, in press.
Vainio, S., Jalkanen, M., and Thesleff, I., 1989, Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J. Cell Biol., 108: 1945–1954.
Vainio, S., Jalkanen, M., Vaahtokari, A., Sahlberg, C., Mali, M., Bernfield, M., and Thesleff, I., 1991, Expression of syndecan gene is induced early, is transient, and correlates with changes in mesenchymal cell proliferation during tooth morphogenesis, Dev. Biol., 147: in press.
Wilkinson, D.G., Bailes, J.A., and McMahon, A.P., 1989, Expression pattern of the FGF-related proto-oncogene int-2 suggests multiple roles in fetal development, Development, 105: 131–136.
Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., and Ornitz, D.M., 1991, Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor, Cell, 64: 841–848.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jalkanen, M., Elenius, K., Salmivirta, M. (1992). Syndecan — A Cell Surface Proteoglycan that Selectively Binds Extracellular Effector Molecules. In: Lane, D.A., Björk, I., Lindahl, U. (eds) Heparin and Related Polysaccharides. Advances in Experimental Medicine and Biology, vol 313. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2444-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2444-5_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2446-9
Online ISBN: 978-1-4899-2444-5
eBook Packages: Springer Book Archive